Novo Nordisk vs. Eli Lilly: Analysts weigh in as the obesity-drug battle heats up
As competition grows in the weight loss drug space, investors are questioning which company will come out on top.
Source link
- Veteran investor Mark Mobius says this ‘historically significant’ factor could set back U.S. stocks
- Demand for AI is driving data center water consumption sky high | TechCrunch
